News Briefs
America’s National Cancer Institute (NCI) has acknowledged oleocanthal as a potential nutraceutical for breast cancer and awarded $399,999 to the company, Oleolive, for the development of the phenolic compound as a functional food to prevent breast cancer.
The funds will be used to research the preventative and therapeutic benefits of oleocanthal in triple negative breast cancer (TNBC) recurrence. Around 50,000 women in the United States are diagnosed with TNBC annually.
See Also:Health NewsA new, safe and effective recurrence inhibitor is urgently needed as the current outlook for TNBC patients is bleak due to high recurrence rates, poor overall survival rates and ineffective available treatments.
Oleocanthal experts Khalid El Sayed and Amal Kaddoumi, who are the company’s chief scientists and researchers at the University of Louisiana-Monroe, co-authored a 2017 study which revealed that oleocanthal was effective in preventing cancer and Alzheimer’s disease in mice and had the potential to become an effective dietary supplement for reducing the risk of developing both conditions.
El Sayed told Olive Oil Times the nutraceutical will be made available to patients once the team has established the desired potency and efficacy of the oleocanthal formulation for preventing TNBC recurrence. He said that further funding would be sought to prepare the formulation for clinical trials on humans.
“[I would] certainly recommend consumption of high-quality extra virgin olive oil daily for not only breast cancer survivors and patients but also for normal healthy people to maintain a condition of well-being based on the significant positive health outcomes documented by several clinical trials and epidemiological studies,” he said.
His recommendation was an average daily consumption of around 20 to 50 milliliters of olive oil per day, depending on an individual’s health and the quality of olive oil consumed. He advised new consumers of olive oil to start with smaller amounts (five to 10 milliliters) and gradually increase the daily dose over time.
More articles on: breast cancer, cancer prevention, oleocanthal
Nov. 9, 2022
Olive Council Publishes Document Archive
The database includes historical trade standards, quality measuring methods and best practices for table olive and olive oil production.
Feb. 10, 2023
New Research Links Olive Oil Consumption and Reduced Autoimmune Occurrence
Researchers found that olive oil consumption promotes healthy gut microbiota and hinders the development of gut pathogens that impair immune function.
Sep. 28, 2023
Regenerative Ag Practices Improve Profitability of Steep-Slope Olive Farms
After finding that soil health improved in abandoned steep-slope olive groves, researchers determined organic and regenerative farming could yield similar results.
Jul. 19, 2023
Researchers in California Test New Solutions for Olive Fruit Fly
Researchers at the University of California are testing a range of insecticide products for efficacy in controlling olive fruit flies.
Aug. 31, 2023
Higher Consumption of Polyphenols Linked to Lower Risk of Contracting Covid-19
Healthy adults who consumed phenols and plant sterols, some of which are present in olive oil, were less likely to contract Covid-19.
Dec. 8, 2022
New Research to Study Impact of Soil Health on Olive Oil Quality
The project seeks to better understand how olive growing affects soil biodiversity and ecological function and how soil health affects olive oil quality and safety.
Oct. 17, 2022
Olive Oil Aisles Result in Superior Supermarket Sales
Grouping all the olive oils in a single aisle and providing information about them resulted in an 18-percent increase in sales. Extra virgin olive oil sales rose 13 percent.
Apr. 11, 2023
Report Highlights Health Benefits, Disproves Myths Surrounding EVOO
The Olive Wellness Institute published a report to educate healthcare officials and the public about the health benefits of extra virgin olive oil.